Home

Sıcak suçluluk acıklı polo like kinase 1 başarısızlık karşı Arabayla uzaklaşmak

Pintard Lab - Mechanisms of nuclear pore complex disassembly by the mitotic  Polo-like kinase 1 (PLK-1) in C. elegans embryos - Institut Jacques Monod
Pintard Lab - Mechanisms of nuclear pore complex disassembly by the mitotic Polo-like kinase 1 (PLK-1) in C. elegans embryos - Institut Jacques Monod

Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of  gamma-herpesviruses and their elimination | PLOS Pathogens
Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination | PLOS Pathogens

Polo-like kinases: structural variations lead to multiple functions |  Nature Reviews Molecular Cell Biology
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology

Structural Basis for Variations in Polo-like Kinase 1 Conformation and  Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive  Abbapolin Inhibitors,ACS Chemical Biology - X-MOL
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors,ACS Chemical Biology - X-MOL

Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect
Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect

Discovery and development of the Polo-like kinase inhibitor volasertib in  cancer therapy | Leukemia
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia

PLK1 - Wikipedia
PLK1 - Wikipedia

Structural basis for the inhibition of Polo-like kinase 1 | Nature  Structural & Molecular Biology
Structural basis for the inhibition of Polo-like kinase 1 | Nature Structural & Molecular Biology

Full article: Polo-like kinase 1 inhibitors in mono- and combination  therapies: a new strategy for treating malignancies
Full article: Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies

Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer
Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer

Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1:  Oncogene or Tumor Suppressor?
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?

Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early  clinical development in oncology. | Semantic Scholar
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar

Polo-like Kinase (PLK) (Inhibitors Agonists Modulators Antagonists) |  MedChemExpress
Polo-like Kinase (PLK) (Inhibitors Agonists Modulators Antagonists) | MedChemExpress

Frontiers | PLK-1 Regulation of Asymmetric Cell Division in the Early C.  elegans Embryo
Frontiers | PLK-1 Regulation of Asymmetric Cell Division in the Early C. elegans Embryo

Polo-Like Kinase - an overview | ScienceDirect Topics
Polo-Like Kinase - an overview | ScienceDirect Topics

Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 |  Journal of Emerging Investigators
Peptidomimetics Targeting the Polo-box Domain of Polo-like Kinase 1 | Journal of Emerging Investigators

Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... |  Download Scientific Diagram
Regulation of mitotic progression by Polo-like kinase 1 (PLK1). PLK1... | Download Scientific Diagram

Yeast Polo-like kinase substrates are nailed with the right tools | Genome  Biology | Full Text
Yeast Polo-like kinase substrates are nailed with the right tools | Genome Biology | Full Text

Polo-like kinases: conservation and divergence in their functions and  regulation | Nature Reviews Molecular Cell Biology
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology

Characteristics and prognostic significance of polo-like kinase-1 (PLK1)  expression in breast cancer
Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer

Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by  HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth

Synthesis and evaluation of small molecule-based derivatives as inhibitors  of polo-box domain of polo-like kinase-1 | Journal of Analytical Science  and Technology | Full Text
Synthesis and evaluation of small molecule-based derivatives as inhibitors of polo-box domain of polo-like kinase-1 | Journal of Analytical Science and Technology | Full Text

Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis  repeat-containing 5 in TP53-mutated hepatocellular carcinoma
Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma

Scheme of polo-like kinase 1 (Plk1) mRNA translation. (A) Cytoplasmic... |  Download Scientific Diagram
Scheme of polo-like kinase 1 (Plk1) mRNA translation. (A) Cytoplasmic... | Download Scientific Diagram

Polo-like kinase 1 (Plk1) haploinsuffcient mouse embryonic fibroblasts... |  Download Scientific Diagram
Polo-like kinase 1 (Plk1) haploinsuffcient mouse embryonic fibroblasts... | Download Scientific Diagram

Phosphorylation of β‐catenin Ser60 by polo‐like kinase 1 drives the  completion of cytokinesis | EMBO reports
Phosphorylation of β‐catenin Ser60 by polo‐like kinase 1 drives the completion of cytokinesis | EMBO reports

Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the  Treatment of Rhabdomyosarcomas
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas

Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in  Epithelial-Mesenchymal Transition and Tumor Metastasis
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis